Sheyu Li

Nov 21, 2024 | mdpi.com | Jing Li |Sheyu Li

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Oct 2, 2023 | frontiersin.org | Sheyu Li |Cong Chen |Jiawei Li

1 IntroductionAs one of the most severe threats to human health, cancer has long captured the attention of industry, academia, and regulatory authorities, driving continuous efforts to develop effective anti-cancer treatment therapies. Notably, from 2010 to 2019, 25% of drugs approved by the FDA were anti-cancer drugs (Brown and Wobst, 2021).